Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia

Molecular and Cellular Biology

Volumn 32, Issue 10, 2012, Pages 1776-1787

  Zhang, Haojian ^a   Li, Huawei ^a   Ho, Ngoc ^a   Li, Dongguang ^b   Li, Shaoguang ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; BCR ABL PROTEIN; CD45 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE DELETION; GENE INDUCTION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DOWN-REGULATION; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; NEOPLASTIC STEM CELLS; PPAR GAMMA; STEAROYL-COA DESATURASE;

EID: 84861385403     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05672-11     Document Type: Article

References (34)

1. Chen Y, Hu Y, Zhang H, Peng C, Li S. 2009. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet. 41:783-792.
2. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. 2008. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18:54-61.
3. Dinarello CA. 2010. Anti-inflammatory agents: present and future. Cell 140:935-950.
4. Dobrzyn P, Dobrzyn A, Miyazaki M, Ntambi JM. 2010. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. J. Lipid Res. 51:2202-2210.
5. Druker BJ, et al. 2001. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344:1038-1042.
6. Falvella FS, et al. 2002. Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 23:1933-1936.
7. Graham SM, et al. 2002. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99:319-325.
8. Hess D, Chisholm JW, Igal RA. 2010. Inhibition of stearoyl-CoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One 5:e11394.
9. Hu Y, et al. 2004. Requirement of Src kinases Lyn, Hck, and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet. 36:453-461.
10. + leukemia in mice. Proc. Natl. Acad. Sci. U. S. A. 103:16870-16875.
11. Juric D, et al. 2007. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. J. Clin. Oncol. 25:1341-1349.
12. Kantarjian H, et al. 2002. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346:645-652.
13. Kim YC, Ntambi JM. 1999. Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem. Biophys. Res. Commun. 266:1-4.
14. Kinder M, et al. 2010. Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism. Blood 115:5012-5022.
15. Kroemer G, Pouyssegur J. 2008. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13:472-482.
16. Li S, Ilaria RL, Jr, Million RP, Daley GQ, Van Etten RA. 1999. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189:1399-1412.
17. Li S, Li D. 2008. DNA microarray technology and data analysis in cancer research. World Scientific 4:37-54.
18. Liu H, et al. 2006. Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18. Blood 107:3683-3692.
19. Melo JV, Barnes DJ. 2007. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer 7:441-453.
20. Middleton MK, et al. 2006. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J. Exp. Med. 203:2529-2540.
21. Morgan-Lappe SE, et al. 2007. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res. 67:4390-4398.
22. Peng C, et al. 2007. Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells. Blood 110:678-685.
23. Peng C, et al. 2010. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice. Blood 115:626-635.
24. Qin X, et al. 2007. Laminar shear stress upregulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells. Cardiovasc. Res. 74:506-514.
25. Radich JP, et al. 2006. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 103:2794-2799.
26. Rahman SM, et al. 2003. Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and downregulates protein-tyrosine phosphatase 1B in muscle. Proc. Natl. Acad. Sci. U. S. A. 100:11110-11115.
27. Ren R. 2005. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 5:172-183.
28. Scaglia N, Chisholm JW, Igal RA. 2009. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One 4:e6812.
29. Scaglia N, Igal RA. 2005. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J. Biol. Chem. 280:25339-25349.
30. Vinciguerra M, et al. 2009. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 upregulation in hepatocytes. Hepatology 49:1176-1184.
31. Wong S, Witte ON. 2004. The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22:247-306.
32. Yahagi N, et al. 2005. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur. J. Cancer 41:1316-1322.
33. Yao-Borengasser A, et al. 2008. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. J. Clin. Endocrinol. Metab. 93:4431-4439.
34. Zang C, et al. 2006. Dual PPARα/γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines. Cell Cycle 5:2237-2243.